Current Assets

Fast Track designation was recently granted for iCo-008 use in bullous pemphigoid (BP) by the US Food and Drug Administration (FDA). The FDA has also recently granted orphan drug designation to iCo-008 for the treatment of bullous pemphigoid.

LEARN MORE

Click below to learn more about our oral Amp B asset.

LEARN MORE